KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income - MinorityNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Teva Pharmaceutical Industries (TEVA) Consolidated Net Income (2016 - 2025)

Historic Consolidated Net Income for Teva Pharmaceutical Industries (TEVA) over the last 17 years, with Q4 2025 value amounting to $690.0 million.

  • Teva Pharmaceutical Industries' Consolidated Net Income rose 35090.91% to $690.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was $1.6 billion, marking a year-over-year increase of 25834.15%. This contributed to the annual value of $1.4 billion for FY2025, which is 17158.16% up from last year.
  • Per Teva Pharmaceutical Industries' latest filing, its Consolidated Net Income stood at $690.0 million for Q4 2025, which was up 35090.91% from $432.0 million recorded in Q3 2025.
  • Teva Pharmaceutical Industries' 5-year Consolidated Net Income high stood at $690.0 million for Q4 2025, and its period low was -$1.8 billion during Q4 2023.
  • Its 5-year average for Consolidated Net Income is -$217.8 million, with a median of -$43.5 million in 2021.
  • Its Consolidated Net Income has fluctuated over the past 5 years, first tumbled by 128658.54% in 2022, then skyrocketed by 35090.91% in 2025.
  • Teva Pharmaceutical Industries' Consolidated Net Income (Quarter) stood at -$151.0 million in 2021, then plummeted by 783.44% to -$1.3 billion in 2022, then crashed by 34.63% to -$1.8 billion in 2023, then soared by 84.69% to -$275.0 million in 2024, then surged by 350.91% to $690.0 million in 2025.
  • Its Consolidated Net Income stands at $690.0 million for Q4 2025, versus $432.0 million for Q3 2025 and $281.0 million for Q2 2025.